Review Article
Bladder Dysfunction and Vesicoureteral Reflux
Table 3
Impact of treatment of bladder
dysfunction on spontaneous resolution of VUR.
| Reference | Age (y) | Patients (number) | VUR grade | Bladder dysfunction | Treatment | Follow/up (y) | Resolution (downgrading) | Controls resolution (downgrading) |
| Koff &
Murtagh 1983 [18]
| 2–14 | 62 | I-IV | OAB | Anticholonergics | 4 | 44%
(16%) | 17%
(0%) | Scholtmeijer
& Griffiths 1990 [33]
| | 25 | I-IV | OAB | Anticholinergics | 1 | 37%
(22%) | No
controls | Scholtmeijer
& Nijman 1994 [19]
| 0.1–15 | 39 | I-IV | OAB | Anti-cholinergics | 3 | 38% (38%) | 40% (16%) | Willemsen
& Nijman 2000 [34]
| 0.1–15 | 102 | I-V | OAB | Anti-cholinergics | 5 | 51% | 55% | Palmer
et al. 2002 [35]
| 6–10 | 25 | I-III | DV | Biofeedback | 1 | 55%
(16%) | No
controls | Kibar
et al. 2007 [36]
| 7.2 | 78 | I-IV | DV | Biofeedback | 0.5 | 63%
(29%) | No
controls | Homsy 1985
[32]
| 4–11 | 35 | I-IV | OAB
+ DV | Oxybutynine | 2.5 | 50% (22%) | No
controls | Snodgrass
1998 [15]
| 3–10 | 128 | | OAB + DV | Oxybutynine | | 45% | 61% |
|
|